R01 MH073853/MH/NIMH NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	2
2009	4
2010	1
2011	7
2012	3
2013	3
2014	3
2024	0

1

Philipp M, Evron T, Caron MG. Philipp M, et al. Prog Mol Biol Transl Sci. 2013;118:225-42. doi: 10.1016/B978-0-12-394440-5.00009-7. Prog Mol Biol Transl Sci. 2013. PMID: 23764056 Review.

2

The physiological relevance of functional selectivity in dopamine signalling.

Urs NM, Caron MG. Urs NM, et al. Int J Obes Suppl. 2014 Jul;4(Suppl 1):S5-8. doi: 10.1038/ijosup.2014.3. Epub 2014 Jul 8. Int J Obes Suppl. 2014. PMID: 27152166 Free PMC article. Review.

3

GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Evron T, Daigle TL, Caron MG. Evron T, et al. Trends Pharmacol Sci. 2012 Mar;33(3):154-64. doi: 10.1016/j.tips.2011.12.003. Epub 2012 Jan 23. Trends Pharmacol Sci. 2012. PMID: 22277298 Free PMC article. Review.

4

Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.

Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Marion S, et al. J Biol Chem. 2014 Apr 25;289(17):11715-11724. doi: 10.1074/jbc.M113.544312. Epub 2014 Mar 11. J Biol Chem. 2014. PMID: 24619418 Free PMC article.

5

Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.

Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. Espinoza S, et al. Mol Pharmacol. 2011 Sep;80(3):416-25. doi: 10.1124/mol.111.073304. Epub 2011 Jun 13. Mol Pharmacol. 2011. PMID: 21670104 Free PMC article.

6

Grk5l controls heart development by limiting mTOR signaling during symmetry breaking.

Burkhalter MD, Fralish GB, Premont RT, Caron MG, Philipp M. Burkhalter MD, et al. Cell Rep. 2013 Aug 29;4(4):625-32. doi: 10.1016/j.celrep.2013.07.036. Epub 2013 Aug 22. Cell Rep. 2013. PMID: 23972986 Free PMC article.

7

PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors.

Abbas AI, Yadav PN, Yao WD, Arbuckle MI, Grant SG, Caron MG, Roth BL. Abbas AI, et al. J Neurosci. 2009 Jun 3;29(22):7124-36. doi: 10.1523/JNEUROSCI.1090-09.2009. J Neurosci. 2009. PMID: 19494135 Free PMC article.

8

Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling.

Dzirasa K, Ramsey AJ, Takahashi DY, Stapleton J, Potes JM, Williams JK, Gainetdinov RR, Sameshima K, Caron MG, Nicolelis MA. Dzirasa K, et al. J Neurosci. 2009 Jun 24;29(25):8215-24. doi: 10.1523/JNEUROSCI.1773-09.2009. J Neurosci. 2009. PMID: 19553461 Free PMC article.

9

Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs.

Wang C, Wu H, Evron T, Vardy E, Han GW, Huang XP, Hufeisen SJ, Mangano TJ, Urban DJ, Katritch V, Cherezov V, Caron MG, Roth BL, Stevens RC. Wang C, et al. Nat Commun. 2014 Jul 10;5:4355. doi: 10.1038/ncomms5355. Nat Commun. 2014. PMID: 25008467 Free PMC article.

10

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.

Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG. Beaulieu JM, et al. J Neurosci. 2007 Jan 24;27(4):881-5. doi: 10.1523/JNEUROSCI.5074-06.2007. J Neurosci. 2007. PMID: 17251429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

23 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year